about
Kallikrein 1-related peptidase b22Coagulation factor XII (Hageman factor)Coagulation factor IXFURINFurin (paired basic amino acid cleaving enzyme)Cathepsin HMatrix metallopeptidase 14V-set immunoregulatory receptorComplement C1rComplement C1r subcomponent likeGamma-glutamyltransferase 1Kallikrein related peptidase 2Serine protease 12Serine protease 3Inactive gamma-glutamyltranspeptidase 2Kallikrein 1Complement component 1, r subcomponent BComplement component 1, r subcomponent AKallikrein 1-related peptidase b16Kallikrein 1-related petidase b26Kallikrein 1-related peptidase b24Kallikrein 1-related peptidase b21Kallikrein 1-related peptidase b27Epidermal growth factor binding protein type BKallikrein 1-related peptidase b11Kallikrein 1-related peptidase b1Kallikrein 1-related peptidase b3Kallikrein 1-related pepidase b4Kallikrein 1-related peptidase b8Kallikrein 1-related peptidase b5Kallikrein 1-related peptidase b9Kallikrein 1Complement component 1, r subcomponent-likeCathepsin HGamma-glutamyltransferase 1Discoidin, CUB and LCCL domain containing 1Matrix metallopeptidase 14 (membrane-inserted)Protease, serine 12 neurotrypsin (motopsin)Hypothetical protein ECIAI39_3940V-set immunoregulatory receptor
P682
Coagulation factor XII (Hageman factor) Washington D.C.: inactive factor XIIa results from Cys-571----Ser substitutionMesotrypsin: a new inhibitor-resistant protease from a zymogen in human pancreatic tissue and fluidIsolation and properties of an abnormal Hageman factor (Factor XII) molecule in a cross-reacting material-positive hageman trait plasmaCathepsin H is an additional convertase of pro-granzyme BBlood clotting factor IX BM Nagoya. Substitution of arginine 180 by tryptophan and its activation by alpha-chymotrypsin and rat mast cell chymaseCalcium-dependent conformational flexibility of a CUB domain controls activation of the complement serine protease C1rActivation of the furin endoprotease is a multiple-step process: requirements for acidification and internal propeptide cleavage
P921
Q14861564-04961E37-C0EF-46F4-B52E-4F75C1752480Q14861564-9A616180-4E83-4BFB-AB1D-5A2B5FB23F4BQ14862724-34FFFEC8-91E9-4189-A26F-1D3B8ECFF146Q14864802-BC857C56-41F3-455A-8D3A-1AA5E7CCFE4BQ14864802-D2933E06-BB20-4627-B1EE-B19355DECABDQ14916427-908EF4B6-2CB0-4733-90FC-0CD35B6B5D6CQ14916430-4057141B-CF7B-42F1-B9A1-6A6C080ABCCFQ21108330-2AEA926D-8546-4F35-BA87-500AE3E38637Q21109573-31D270BD-5E15-4FD1-9A56-B9F228AB3050Q21109573-CF022938-66BD-4488-BFC6-258F451CD609Q21110365-D8653CBA-AF34-440B-A6C5-36A8BC639F32Q21111742-0488279A-82EF-4DB8-8E76-0C98F422CA57Q21111742-F1F7D30A-E55B-4AEE-BE7C-3B7230C9CA94Q21111775-AAC9190A-3AC4-4D17-98F9-7CE0185AB42AQ21114607-74A0885D-BA75-4726-9F46-F3384C49D0A3Q21121515-60320EF2-B4E6-4200-BC60-557E691CE669Q21124843-0E6724CC-E718-48A9-B1AC-A855CE5FD28AQ21125508-F0CE26EA-CB23-4333-990B-9B6BD4975CEAQ21173469-EE44432D-BB88-45AE-BFB0-8125FC0D0AAEQ21207617-490B6FCB-88C0-4CCD-A9BA-FBD308490BDCQ21426264-677BA40F-1344-4235-949C-2022C3C526DBQ21426271-57693FC0-E704-42A7-92E3-8B60F8F8B5A8Q21428408-24D6A532-7230-4CCB-9E4A-0D29BD0C36B3Q21428411-3803EBC5-F5C8-45BC-85AC-4105B63266B5Q21428411-389EF806-2E70-409C-B1E6-B2ACCABBFEAEQ21428413-ECB0FFD4-0660-46CE-8F20-307EBA856B8DQ21428414-B755A218-BD92-4347-AD2E-2621C23F1B14Q21428417-849C8F64-EB1C-4590-A49A-D9629F7DDD44Q21433482-50D5D915-7990-47C3-9B39-EB026E685C01Q21433482-C5468965-F021-4A55-95CB-56D2CB230114Q21433532-E8FC82E4-4FE6-4892-BCFD-78423A268B15Q21433538-DF70E2DA-B2F2-438A-98C4-BCB5C75E1EE9Q21433539-67B582EC-7C99-4227-B3A2-5B800B603C7AQ21433540-68942EAC-5522-4EA4-A194-F9E3529CAE58Q21433541-3110A08B-38CC-4C8B-BC9A-E05783ED4111Q21433542-81AB35FA-4991-460E-B5D3-E2ADD10C13D7Q21433543-BAA8DBFC-90CA-4CD8-88B0-D7781995043DQ21433543-E508D932-392F-4AC3-B852-9C5BF169D767Q21494661-E326B1EC-0DD7-4966-AFF5-DEA1397D7DF0Q21494886-20E9A236-CA92-4000-BC4B-D2B7248F3E1D
P682
Q24301765-912F7FEF-D65B-4488-988C-0F17AE606A81Q24301887-C079C9B1-1C70-4AA6-9445-A7445B775DB9Q24302040-30E922FE-8888-4A89-8C6A-438AE205067BQ24309194-07B404B9-E5A9-4476-951A-7AC7794E58D4Q24337140-3B7EE20B-E021-4614-A6D4-BA8CC0709A80Q28910359-2A82E9E5-05C1-453C-B66E-5E51EAEFEDBAQ28941774-5434E46D-7318-4ED9-943F-FD7C4652A81E
P921
description
The proteolytic processing of an inactive enzyme to an active form.
@en
biologisch proces
@nl
name
zymogen activation
@en
type
label
zymogen activation
@en
altLabel
GO:0031638
@en
zymogen activation by proteolytic cleavage
@en
prefLabel
zymogen activation
@en
P2888
P686
GO:0031638